MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases

por Nagy, E, Gajjar, K B, Patel, I I, Taylor, S, Martin-Hirsch, P L, Stringfellow, H F, Martin, F L, Phillips, D H
Publicado 2014